Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.
Other companies in Revelation Biosciences’s space includes: Can Fite Biofarma (AMEX:CANF), Genprex (NASDAQ:GNPX), Alaunos Therapeutics (NASDAQ:TCRT), VivoSim Labs (NASDAQ:VIVS) and Cardio Diagnostics Hldgs (NASDAQ:CDIO).
Revelation Biosciences has a consensus price target of $15.00.
The stock price for Revelation Biosciences (NASDAQ: REVB) is $0.9801 last updated November 12, 2025 at 7:56 PM EST.
There are no upcoming dividends for Revelation Biosciences.
Revelation Biosciences’s Q3 earnings are confirmed for Thursday, November 6, 2025.
There is no upcoming split for Revelation Biosciences.
Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.